Akebia Therapeutics (AKBA) Q2 2026 Earnings

7MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.04
-0.02
0.01
0.03

Details

Expected EPS
-0.028
Actual EPS
-0.03
Surprise EPS
-0
Surprise Percent
+7.14%

Description

Akebia Therapeutics (AKBA) has reported earnings of -0.03 per share for Q2 2026.

0 Comments

Share your thoughts